Gadospin F—Enhanced Magnetic Resonance Imaging for Diagnosis and Monitoring of Atherosclerosis: Validation with Transmission Electron Microscopy and X-Ray Fluorescence Imaging in the Apolipoprotein E—Deficient Mouse

The aim of this study was to investigate the feasibility of noninvasive monitoring of plaque burden in apolipoprotein E–deficient (ApoE −/− ) mice by Gadospin F (GDF)-enhanced magnetic resonance imaging (MRI). Gadolinium uptake in plaques was controlled using transmission electron microscopy (TEM) a...

Full description

Saved in:
Bibliographic Details
Main Authors: Caroline Jung, Tanja Dučić, Rudolph Reimer, Eva Koziolek, Fabian Kording, Markus Heine, Gerhard Adam, Harald Ittrich, Michael G. Kaul
Format: Article
Language:English
Published: SAGE Publishing 2015-01-01
Series:Molecular Imaging
Online Access:https://doi.org/10.2310/7290.2014.00039
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832544571723087872
author Caroline Jung
Tanja Dučić
Rudolph Reimer
Eva Koziolek
Fabian Kording
Markus Heine
Gerhard Adam
Harald Ittrich
Michael G. Kaul
author_facet Caroline Jung
Tanja Dučić
Rudolph Reimer
Eva Koziolek
Fabian Kording
Markus Heine
Gerhard Adam
Harald Ittrich
Michael G. Kaul
author_sort Caroline Jung
collection DOAJ
description The aim of this study was to investigate the feasibility of noninvasive monitoring of plaque burden in apolipoprotein E–deficient (ApoE −/− ) mice by Gadospin F (GDF)-enhanced magnetic resonance imaging (MRI). Gadolinium uptake in plaques was controlled using transmission electron microscopy (TEM) and x-ray fluorescence (XRF) microscopy. To monitor the progression of atherosclerosis, ApoE −/− ( n = 5) and wild-type ( n = 2) mice were fed a Western diet and imaged at 5, 10, 15, and 20 weeks. Contrast-enhanced MRI was performed at 7 T Clinscan (Bruker, Ettlingen, Germany) before and 2 hours after intravenous injection of GDF (100 μmol/kg) to determine the blood clearance. Plaque size and contrast to noise ratio (CNR) were calculated for each time point using region of interest measurements to evaluate plaque progression. Following MRI, aortas were excised and GDF uptake was cross-validated by TEM and XRF microscopy. The best signal enhancement in aortic plaque was achieved 2 hours after application of GDF. No signal differences between pre- and postcontrast MRI were detectable in wild-type mice. We observed a gradual and considerable increase in plaque CNR and size for the different disease stages. TEM and XRF microscopy confirmed the localization of GDF within the plaque. GDF-enhanced MRI allows noninvasive and reliable estimation of plaque burden and monitoring of atherosclerotic progression in vivo.
format Article
id doaj-art-bd4493eb2ccb40b5ae9ffb5eada1a7ad
institution Kabale University
issn 1536-0121
language English
publishDate 2015-01-01
publisher SAGE Publishing
record_format Article
series Molecular Imaging
spelling doaj-art-bd4493eb2ccb40b5ae9ffb5eada1a7ad2025-02-03T10:08:10ZengSAGE PublishingMolecular Imaging1536-01212015-01-011410.2310/7290.2014.0003910.2310_7290.2014.00039Gadospin F—Enhanced Magnetic Resonance Imaging for Diagnosis and Monitoring of Atherosclerosis: Validation with Transmission Electron Microscopy and X-Ray Fluorescence Imaging in the Apolipoprotein E—Deficient MouseCaroline JungTanja DučićRudolph ReimerEva KoziolekFabian KordingMarkus HeineGerhard AdamHarald IttrichMichael G. KaulThe aim of this study was to investigate the feasibility of noninvasive monitoring of plaque burden in apolipoprotein E–deficient (ApoE −/− ) mice by Gadospin F (GDF)-enhanced magnetic resonance imaging (MRI). Gadolinium uptake in plaques was controlled using transmission electron microscopy (TEM) and x-ray fluorescence (XRF) microscopy. To monitor the progression of atherosclerosis, ApoE −/− ( n = 5) and wild-type ( n = 2) mice were fed a Western diet and imaged at 5, 10, 15, and 20 weeks. Contrast-enhanced MRI was performed at 7 T Clinscan (Bruker, Ettlingen, Germany) before and 2 hours after intravenous injection of GDF (100 μmol/kg) to determine the blood clearance. Plaque size and contrast to noise ratio (CNR) were calculated for each time point using region of interest measurements to evaluate plaque progression. Following MRI, aortas were excised and GDF uptake was cross-validated by TEM and XRF microscopy. The best signal enhancement in aortic plaque was achieved 2 hours after application of GDF. No signal differences between pre- and postcontrast MRI were detectable in wild-type mice. We observed a gradual and considerable increase in plaque CNR and size for the different disease stages. TEM and XRF microscopy confirmed the localization of GDF within the plaque. GDF-enhanced MRI allows noninvasive and reliable estimation of plaque burden and monitoring of atherosclerotic progression in vivo.https://doi.org/10.2310/7290.2014.00039
spellingShingle Caroline Jung
Tanja Dučić
Rudolph Reimer
Eva Koziolek
Fabian Kording
Markus Heine
Gerhard Adam
Harald Ittrich
Michael G. Kaul
Gadospin F—Enhanced Magnetic Resonance Imaging for Diagnosis and Monitoring of Atherosclerosis: Validation with Transmission Electron Microscopy and X-Ray Fluorescence Imaging in the Apolipoprotein E—Deficient Mouse
Molecular Imaging
title Gadospin F—Enhanced Magnetic Resonance Imaging for Diagnosis and Monitoring of Atherosclerosis: Validation with Transmission Electron Microscopy and X-Ray Fluorescence Imaging in the Apolipoprotein E—Deficient Mouse
title_full Gadospin F—Enhanced Magnetic Resonance Imaging for Diagnosis and Monitoring of Atherosclerosis: Validation with Transmission Electron Microscopy and X-Ray Fluorescence Imaging in the Apolipoprotein E—Deficient Mouse
title_fullStr Gadospin F—Enhanced Magnetic Resonance Imaging for Diagnosis and Monitoring of Atherosclerosis: Validation with Transmission Electron Microscopy and X-Ray Fluorescence Imaging in the Apolipoprotein E—Deficient Mouse
title_full_unstemmed Gadospin F—Enhanced Magnetic Resonance Imaging for Diagnosis and Monitoring of Atherosclerosis: Validation with Transmission Electron Microscopy and X-Ray Fluorescence Imaging in the Apolipoprotein E—Deficient Mouse
title_short Gadospin F—Enhanced Magnetic Resonance Imaging for Diagnosis and Monitoring of Atherosclerosis: Validation with Transmission Electron Microscopy and X-Ray Fluorescence Imaging in the Apolipoprotein E—Deficient Mouse
title_sort gadospin f enhanced magnetic resonance imaging for diagnosis and monitoring of atherosclerosis validation with transmission electron microscopy and x ray fluorescence imaging in the apolipoprotein e deficient mouse
url https://doi.org/10.2310/7290.2014.00039
work_keys_str_mv AT carolinejung gadospinfenhancedmagneticresonanceimagingfordiagnosisandmonitoringofatherosclerosisvalidationwithtransmissionelectronmicroscopyandxrayfluorescenceimagingintheapolipoproteinedeficientmouse
AT tanjaducic gadospinfenhancedmagneticresonanceimagingfordiagnosisandmonitoringofatherosclerosisvalidationwithtransmissionelectronmicroscopyandxrayfluorescenceimagingintheapolipoproteinedeficientmouse
AT rudolphreimer gadospinfenhancedmagneticresonanceimagingfordiagnosisandmonitoringofatherosclerosisvalidationwithtransmissionelectronmicroscopyandxrayfluorescenceimagingintheapolipoproteinedeficientmouse
AT evakoziolek gadospinfenhancedmagneticresonanceimagingfordiagnosisandmonitoringofatherosclerosisvalidationwithtransmissionelectronmicroscopyandxrayfluorescenceimagingintheapolipoproteinedeficientmouse
AT fabiankording gadospinfenhancedmagneticresonanceimagingfordiagnosisandmonitoringofatherosclerosisvalidationwithtransmissionelectronmicroscopyandxrayfluorescenceimagingintheapolipoproteinedeficientmouse
AT markusheine gadospinfenhancedmagneticresonanceimagingfordiagnosisandmonitoringofatherosclerosisvalidationwithtransmissionelectronmicroscopyandxrayfluorescenceimagingintheapolipoproteinedeficientmouse
AT gerhardadam gadospinfenhancedmagneticresonanceimagingfordiagnosisandmonitoringofatherosclerosisvalidationwithtransmissionelectronmicroscopyandxrayfluorescenceimagingintheapolipoproteinedeficientmouse
AT haraldittrich gadospinfenhancedmagneticresonanceimagingfordiagnosisandmonitoringofatherosclerosisvalidationwithtransmissionelectronmicroscopyandxrayfluorescenceimagingintheapolipoproteinedeficientmouse
AT michaelgkaul gadospinfenhancedmagneticresonanceimagingfordiagnosisandmonitoringofatherosclerosisvalidationwithtransmissionelectronmicroscopyandxrayfluorescenceimagingintheapolipoproteinedeficientmouse